### Summary

The paper proposes a novel approach to medical image segmentation by using synthetic tumors as a validation set. This method addresses the limitations of traditional validation sets, which are often small and biased, by providing a large, diverse, and unbiased validation set. The authors demonstrate the effectiveness of their approach through experiments on liver tumor segmentation, showing improved performance, especially for tiny tumors.

### Soundness

3

### Presentation

3

### Contribution

3

### Strengths

1. The paper introduces a novel approach to medical image segmentation by using synthetic tumors as a validation set, which is a creative and innovative idea.
2. The authors provide a clear and well-structured explanation of their methodology, including the steps involved in generating synthetic tumors and the continual learning framework.
3. The paper demonstrates the effectiveness of the proposed method through empirical evidence, showing improved performance in liver tumor segmentation tasks.
4. The paper is well-written and organized, making it easy to follow the authors' arguments and understand their contributions.

### Weaknesses

#### Some Related Works


#### comment

1. The paper's motivation is unclear and requires further clarification. The authors should provide a more detailed explanation of why they chose liver tumor segmentation and what specific challenges this application presents that justify their proposed method. The current justification, based on the potential for early detection, is not sufficiently compelling, and the paper lacks a clear articulation of the limitations of existing methods in this specific context. A more thorough discussion of the clinical relevance and the specific advantages of their approach over existing methods is needed.
2. The paper lacks a comprehensive comparison with other state-of-the-art methods in synthetic data generation and validation set construction. The authors should include a more extensive literature review and compare their method against established techniques, such as generative adversarial networks (GANs) or variational autoencoders (VAEs), to demonstrate the novelty and effectiveness of their approach. The absence of such comparisons makes it difficult to assess the true contribution of the proposed method.
3. The paper does not adequately address the potential biases introduced by the synthetic data generation process. The authors should discuss how the synthetic data might differ from real data and what steps they have taken to mitigate these biases. Specifically, the paper should address the potential for the synthetic data to oversimplify the complexity of real-world tumors, which could lead to models that perform poorly in clinical practice. The lack of discussion on this critical aspect undermines the reliability of the proposed method.
4. The paper's evaluation is limited to a single application (liver tumor segmentation) and does not explore the generalizability of the proposed method to other medical imaging tasks or datasets. The authors should demonstrate the versatility of their approach by applying it to other domains, such as lung cancer detection or prostate cancer segmentation, to show that the method is not specific to liver tumors. This would significantly strengthen the paper's claims and broaden its impact.

### Suggestions

The authors should provide a more detailed justification for their choice of liver tumor segmentation as the primary application. While early detection is a relevant goal, the paper needs to articulate specific challenges in liver tumor segmentation that are not adequately addressed by existing methods. This should include a discussion of the unique characteristics of liver tumors, such as their heterogeneous nature, the variability in size and shape, and the potential for rapid progression. Furthermore, the authors should clearly explain why their proposed method is particularly well-suited to address these specific challenges. A more thorough discussion of the clinical context and the limitations of current approaches would significantly strengthen the motivation for this work. The authors should also consider comparing their method against other state-of-the-art techniques for liver tumor segmentation to provide a more comprehensive evaluation of its performance.

To address the lack of comprehensive comparison, the authors should include a more extensive literature review and compare their method against established techniques for synthetic data generation and validation set construction. This should include a discussion of methods such as generative adversarial networks (GANs) and variational autoencoders (VAEs), which are commonly used for generating synthetic data. The authors should not only compare the performance of their method against these techniques but also discuss the advantages and disadvantages of each approach. This would help to establish the novelty and effectiveness of their proposed method. Furthermore, the authors should provide a detailed analysis of the computational cost and the complexity of their method compared to other techniques. This would help to assess the practical feasibility of their approach.

Finally, the authors need to address the potential biases introduced by the synthetic data generation process. This should include a discussion of the parameters used in the synthetic data generation process and how they were chosen. The authors should also discuss the potential for the synthetic data to oversimplify the complexity of real-world tumors and how they have mitigated this issue. For example, they could discuss how they have ensured that the synthetic tumors capture the variability in tumor morphology, size, and location. Furthermore, the authors should provide a more detailed analysis of the impact of the synthetic data on the performance of the model. This should include an analysis of the model's performance on real-world data and the potential for the synthetic data to introduce biases. The authors should also consider evaluating their method on other medical imaging tasks or datasets to demonstrate its generalizability.

### Questions

1. How does the proposed method compare to other synthetic data generation techniques in terms of performance and generalizability?
2. What measures have been taken to ensure the realism and diversity of the synthetic tumors generated, and how might this affect the model's performance on real-world data?

### Rating

6

### Confidence

3

**********
